Prostatis Group’s Starbucks SBUX Stock Holding History

Prostatis Group’s Portfolio SBUX Stock Details SBUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,455	Closed	-$132K	–	204
2023 Q2	$132K	Buy	+17,455	New	+$1.81M	0.06%	125
2020 Q4	–	Sell	-3,130	Closed	-$269K	–	85
2020 Q3	$269K	Buy	+3,130	New	+$250K	0.25%	69

Other funds holding SBUX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prostatis Group's SBUX Position: Q3 2023 in Review

Prostatis Group sold out of Starbucks (SBUX) in Q3 2023, closing a stake of 17,455 shares — an estimated $132K sold.

Prostatis Group first reported a position in SBUX in Q3 2020 and held it in 2 quarters. The position peaked at $269K in Q3 2020. 2,301 funds tracked by Wall St. Rank hold SBUX as of Q3 2023.

Prostatis Group reported no remaining Starbucks position as of Q3 2023 after selling out during the quarter.
Prostatis Group sold 17,455 Starbucks shares in Q3 2023, an estimated $132K.
Prostatis Group first reported a position in Starbucks in Q3 2020 and held it in 2 quarters.
Prostatis Group's Starbucks position peaked at $269K in Q3 2020.
2,301 funds tracked by Wall St. Rank held Starbucks as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.